Pillar Biosciences Partners with AstraZeneca to Help Accelerate Access to Liquid Biopsy Testing
September 10, 2024
Partnership aims to make liquid biopsy tumor profiling more accessible to local laboratories, clinicians and patients through rapid, affordable, kitted NGS testing solutions. Natick, MA – Pillar Biosciences, Inc., has entered into a strategic partnership with AstraZeneca to expand laboratory access to molecular testing, using rapid, Next Generation Sequencing (NGS)-based liquid biopsy tumor profiling panels for [...]
Culture Biosciences and Google Cloud Announce Collaboration to Revolutionize Bioprocess Development
September 10, 2024
Gemini AI integration with first upstream cloud-connected bioreactors will allow scientists in R&D bioprocess development to achieve optimal outcomes in less time. SAN FRANCISCO, CALIFORNIA, UNITED STATES -- Culture Biosciences—a leader in automated bioprocess development, optimization and data science —announces a strategic collaboration with Google Cloud that will integrate Culture’s real-time data monitoring and cloud-connected [...]
September 10, 2024
Bergisch Gladbach – Miltenyi Biotec will supply lentiviral vector for TECELRA® (afamitresgene autoleucel), the first-ever TCR T-cell therapy for solid tumors approved by FDA on August 1, 2024. The commercial manufacturing of the lentiviral vector used in production of TECELRA is performed by Miltenyi Bioindustry, the global division of Miltenyi Biotec dedicated to contract development [...]
From molecule to market: Endress+Hauser, Mangrove Systems collab for measurement and monitoring
September 9, 2024
Companies will help drive accuracy and transparency in carbon measurement Driving accuracy and transparency in carbon measurement Endress+Hauser, a global leader in measurement and automation technology, has collaborated with Mangrove Systems to enhance the measurement and monitoring capabilities of carbon dioxide removal (CDR) and carbon capture and storage (CCS) value chains. This collaboration aims to [...]
September 9, 2024
KNOXVILLE, Tenn. – Enigma Biomedical USA (EB) today announced a collaboration with Alamar Biosciences in the field of neurology. Through this collaboration, EB has a non-exclusive right to introduce Alamar’s protein detection and measurement technologies, including its ARGO™ HT instrument and NULISA™ reagent kits, to academic and pharma customers in the field of neurology research. [...]
September 9, 2024
Pioneering automation project will enhance the speed and scale of brain disease research Houston, TX — The Jan and Dan Duncan Neurological Research Institute (‘Duncan NRI’) at Texas Children’s Hospital, a world-class neuroscience research institute based in Houston, announces a groundbreaking advancement in its research capabilities, with the implementation of a state-of-the-art automation platform for human cellular model generation, [...]
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
September 9, 2024
New CLIA-certified lab ensures seamless transition from early assay development and testing to full companion diagnostics commercialization SANTA CLARA, Calif. -- Agilent Technologies Inc. , (NYSE: A) today announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, following receipt of California State clinical laboratory license and Clinical Laboratory Improvement Amendments (CLIA) certificate of compliance. [...]
September 9, 2024
Pioneering automation project will enhance the speed and scale of brain disease research HOUSTON -- The Jan and Dan Duncan Neurological Research Institute (‘Duncan NRI’) at Texas Children’s Hospital, a world-class neuroscience research institute based in Houston, announces a groundbreaking advancement in its research capabilities, with the implementation of a state-of-the-art automation platform for human cellular model generation, [...]
September 9, 2024
FREDERICTON, New Brunswick – LuminUltra, the global leader in applied molecular diagnostics, today announced the acquisition of the legionella testing business assets of Genomadix Inc, along with rights to develop and commercialize further assays and test methods in water, energy and food and beverage markets globally using the Genomadix Cube™ qPCR (quantitative polymerase chain reaction) Platform. With [...]
IonOpticks partners with Adelis to accelerate global expansion and innovation
September 9, 2024
IonOpticks responds to growing global market needs for proteomics tools by partnering with Nordic private equity firm MELBOURNE, Australia and STOCKHOLM -- IonOpticks, a leading global producer of high-performance chromatography columns, announces its partnership with Adelis Equity Partners ("Adelis"). The Nordic private equity firm is renowned for partnering with and accelerating the growth of companies in their [...]

